Johnson v. C R Bard Incorporated

District Court, W.D. Wisconsin·Decided June 4, 2021·No. 3:19-cv-00760·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WISCONSIN

NATALIE JOHNSON,

Plaintiff, ORDER v. 19-cv-760-wmc C.R. BARD INC. and BARD PERIPHERAL VASCULAR INC.,

Defendants.

Before the court is the parties’ request for ruling on objections to certain deposition designations as to David Ciavarella. DEPON- PL DEF PL RESPONSE TO COURT ENT AFFIRM OBJECTIONS OBJECTIONS RULING Defendants’ Testimony involves the OVERRULED object to this Recovery, which is the testimony in its predicate filter to the entirety as it has G2. The G2, the G2x, no relation to the the Eclipse, and the Meridian filter. Meridian are the same Dr. Ciavarella filter with the exception testified that his of a removal hook on role as medical the G2X and director stopped electropolishing on the in 2008 when Dr. Eclipse and the anchors Altonaga took on the Meridian. over (see, 44:24- Testimony is relevant to 45:6). This whether the filter []had testimony has no a defective design, Bard's relevance to the negligence and failure to issues in this case. warn claims, which are Bard objects to at issue. The Plaintiff’s G2/G2X/Eclipse/Meridia references to n and the Recovery filter “Admitted in the suffered similar rates of a basis for discussing the failures of allowing a the Recovery is directly designation to related to the played, or G2/G2X/Eclipse/Meridia overruling an n. There is no unfair objection, and prejudice. submits that the testimony should be consider based on the facts and applicable law and rulings in this case. The Peterson case involved a different filter, different claims, and was decided under different state law. Ciavarella, 11:09- Admitted in Peterson David 11:11 11/12/2013 Ciavarella, 13:12- Admitted in Peterson David 13:19 11/12/2013 beginning with "You've been with…" Ciavarella, 36:14- Admitted in Peterson David 37:03 11/12/2013 David 44:18 designation. Lines The Federal Rules of 11/12/2013 44:08-12 are an Evidence do not answer, but no prohibit a party from question was questioning witnesses designated. Lines about admissible 14-18 are documents the witness cumulative of Dr. does not recall having Altonaga’s seen before. “Personal testimony. knowledge of a fact ‘is not an absolute’ to Rule 602's foundational requirement . . . .”, United States v. Cuti, 702 F.3d. 453, 459 (2nd Cir. 2013). . “What if you had known “ questions are acceptable. Id., 459 (2nd Cir. 2013). Testimony involves the Recovery, which is the predicate filter to the G2. The G2, the G2x, the Eclipse, and the Meridian are the same filter with the exception of a removal hook on the G2X and electropolishing on the Eclipse and the anchors on the Meridian. Testimony is relevant to whether the filter filter had a defective design, Bard's negligence and failure warn claims, which are at issue. The G2/G2X/Eclipse/Meridia n and the Recovery filter suffered similar rates of various failures and discussing the failures of the Recovery is directly related to the G2/G2X/Eclipse/Meridia n. There is no unfair Testimony is relevant because it establishes that the doctors evaluating adverse events and complications of the Recovery filter did not see patients regarding filters or for any other issues. Witness knew answer to question.

Ciavarella, 44:24- Admitted in Peterson David 45:06 11/12/2013 Ciavarella, 46:14- Cumulative of Dr. Admitted in Peterson OVERRULED David 46:23 ALtonaga’s The testimony is not 11/12/2013 testimony. cumulative and Plaintiff is not "needless presenting cumulative evidence". The question was never asked of Dr. Altonaga. Ciavarella, 70:06- Rules 401, 402 Admitted in Peterson OVERRULED David 70:08 and 403. There is The question and 11/12/2013 beginning no failure to recall answer do not discuss with "you claim in this case. a[] "recall" it asks if Bard don't could withdraw a have…" product from the market voluntarily. The testimony is relev[a]nt to Ba[r]d's negligence and is not unfairly prejudicial. David 70:13 and 403. There is The question and 11/12/2013 no failure to recall answer do not discuss claim in this case. a[] "recall" it asks if Bard could withdraw a product from the market voluntarily. The testimony is relev[a]nt to Ba[r]d's negligence and is not unfairly prejudicial. Ciavarella, 83:06- Admitted in Peterson David 83:08 11/12/2013 Ciavarella, 83:11- Admitted in Peterson David 83:16 11/12/2013 Ciavarella, 84:10- The counters at Admitted in Peterson OVERRULED David 84:15 pages 84-86 are Witness's job 11/12/2013 beginning necessary for responsibility included with "a completeness. review of product medical labeling, so he had to doctor," have knowledge of this subject to do his job. See, e.g., 20:7-14. see also 91:13-17; 92:18-24. Witness's job also included assessing as part of health hazard evaluation whether the risk is obvious to the implanting physician. 8/29/12 deposition at 60:16-61:6. Witness made decisions and recommendations with respect to the Recovery regarding implanting physician's role in integrating risk information and making decisions. 7/29/14 deposition at 164:24- 165:6. Testimony designated by Bard knowledge of and was involved in warnings and the risk/benefit analysis of doctors related to same. E.g., 80:18-25. In fact, the witness conducted a focus group regarding how doctors evaluate the risk/benefit ratio with respect to the Recovery filter. See Bard's design[]ation, 7/29/04 deposition at 140:1-19. Thus, witness has knowledge of this subject matter. FCP 32(6) and FRE 106 only require completeness that "in fairness ought to be considered at the same time". Defendants have not demonstrated why this testimony, in the name of fairness, must be considered at the same time as Plaintiff's designation. David 84:20 pages 84-86 are Warnings and what 11/12/2013 necessary for medical professional completeness. knew or should have known directly relate to consumer expectation. Witness's job responsibility included review of product labeling, so he had to have knowledge of this subject to do his job. See, e.g., 20:7-14. see also 91:13-17; 92:18-24. Witness's job also included assessing as part of health hazard evaluation whether the risk is obvious to the implanting physician. 8/29/12 deposition at 60:16-61:6. Witness made decisions and recommendations with respect to the Recovery regarding implanting physician's role in integrating risk information and making decisions. 7/29/14 deposition at 164:24- 165:6. Testimony designated by Bard establishes witness had knowledge of and was involved in warnings and the risk/benefit analysis of doctors related to same. E.g., 80:18-25. In fact, the witness conducted a focus group regarding how doctors evaluate the risk/benefit ratio with respect to the Recovery filter. See Bard's design[]ation, 140:1-19. Thus, witness has knowledge of this subject matter. The witness answered the question. The Federal Rules of Evidence do not prohibit a party from questioning witnesses about admissible documents the witness does not recall having seen before. “Personal knowledge of a fact ‘is not an absolute’ to Rule 602's foundational requirement . . . .”, United States v. Cuti, 702 F.3d. 453, 459 (2nd Cir. 2013). . “What if you had known “ questions are acceptable. Id., 459 (2nd Cir. 2013). FCP 32(6) and FRE 106 only require completeness that "in fairness ought to be considered at the same time". Defendants have not demonstrated why this testimony, in the name of fairness, must be considered at the same time as Plaintiff's designation.

Free access — add to your briefcase to read the full text and ask questions with AI

Johnson v. C R Bard Incorporated, (W.D. Wis. 2021).

Johnson v. C R Bard Incorporated (Johnson v. C R Bard Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Randy Russell v. Whirlpool Corp.
702 F.3d 450 (Eighth Circuit, 2012)